StockData
Hinge Health, Inc. logo

Hinge Health, Inc. (HNGE) stock analysis

HNGENYSEServices-Computer Processing & Data PreparationFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/30
$114.41−6.88 (-5.67%)

Close on Nov 17, 2026Market cap $9.23BP/E –Yield –

StockData Score

Prices as of Nov 16, 2026How the score works

Value0Growth3Performance2Health6Dividend0

Mixed11 of 30 checks passed

Hinge Health passes 11 of the 30 checks behind our score; 17 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
3/6
Past performance
2/6
Financial health
6/6
Dividend
0/6

What stands out

  • No debt

    Hinge Health has no borrowings on its latest balance sheet.

  • Interest well covered

    No meaningful interest expense to cover.

  • Debt covered by cash flow

    There is no debt to cover.

  • Low bankruptcy risk

    The Altman Z-score is 11.99; above 3 is the safe zone and below 1.8 the distress zone.

What to watch

  • P/B above the industry

    Hinge Health's price-to-book of 28.42 is above the Computer Programming, Data Processing, and Other Computer Related Services median of 3.04.

  • No dividend

    Hinge Health has not paid a dividend in the last twelve months.

Valuation0/6
  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B above the industry

    Hinge Health's price-to-book of 28.42 is above the Computer Programming, Data Processing, and Other Computer Related Services median of 3.04.

  • Price against fair value

    We could not estimate a fair value: it needs at least two valuation methods with positive inputs.

  • Margin of safety

    Depends on the fair value estimate.

Growth3/6
  • Revenue growth over 3 years

    Needs three years of positive revenue.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 49.8% over the last twelve months; the Computer Programming, Data Processing, and Other Computer Related Services median is 10.6%.

  • Guidance raised

    Hinge Health raised its Full Year 2026 revenue guidance outlook on Aug 4, 2026.

  • Gross margin improving

    Gross margin was 84.5% over the last twelve months, against 77.7% a year earlier.

Past performance2/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity above the industry

    Hinge Health's return on equity of 42.1% is above the Computer Programming, Data Processing, and Other Computer Related Services median of -1.0%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin against its history

    Needs five years of revenue and net income.

  • Net margin above the industry

    Hinge Health's net margin of 15.1% is above the Computer Programming, Data Processing, and Other Computer Related Services median of -4.8%.

Financial health6/6
  • No debt

    Hinge Health has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    No meaningful interest expense to cover.

  • Short-term assets cover short-term debts

    Current assets are 1.34 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 11.99; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6
  • No dividend

    Hinge Health has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

We don't publish a fair value for Hinge Health. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$216.21M
Value traded per 1% price move
$87.93M

Downside

High risk

Typical loss in a bad month
28.1%
Volatility (annualized)
51%
Sharpe ratio, 1 year
3.61
Beta to the S&P 500 (5Y)
1.38

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2022 to 2025

Gross margin

79.6%

Operating margin

-92.9%

Net margin

-89.9%

See a number that looks wrong?